The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 3, open-label, randomized study to evaluate the efficacy and safety of single-agent belantamab mafodotin (belamaf) compared to pomalidomide plus low-dose dexamethasone (Pd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): DREAMM-3.
 
Katja Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene (Inst); Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline (Inst); Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Sanofi (Inst); Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
Vania TM Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; Janssen-Cilag; Pfizer; Sanofi; Takeda
Speakers' Bureau - Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
 
Atanas Radinoff
Honoraria - Abbvie; Novartis; Pfizer; Roche; SOBI; Swixx BioPharma
Consulting or Advisory Role - Roche; SOBI; Swixx BioPharma
Travel, Accommodations, Expenses - Roche
 
Sosana Delimpasi
Honoraria - Amgen; GlaxoSmithKline; Janssen; Takeda
 
Gabor Mikala
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Gedeon Richter; Janssen; Roche; Takeda
Consulting or Advisory Role - AbbVie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Roche; Takeda
Research Funding - Abbvie
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Takeda
 
Tamas Masszi
Consulting or Advisory Role - Abbvie; BMS; Janssen; Novartis; Pfizer; Takeda
 
Jian Li
No Relationships to Disclose
 
Marcelo Capra
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Sanofi
 
Morio Matsumoto
No Relationships to Disclose
 
Neal Sule
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer
 
Mary Li
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
 
Astrid McKeown
Employment - Charles River Analytics (I); GlaxoSmithKline
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; GlaxoSmithKline (I); HALEON; HALEON (I); Novartis; Novartis (I)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Wei He
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Shelley Bright
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Brooke Currie
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Julia Boyle
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda